What is the entry criterion and why is it required?
▼
The entry criterion - at least one episode of swelling, pain, or tenderness in a peripheral joint or bursa - ensures that the scoring criteria are only applied to patients with genuine inflammatory articular symptoms. It excludes asymptomatic hyperuricemia, which is common in the general population and does not require gout classification. Without this step, the scoring domains would be applied to patients who have never had a clinical flare, which would generate meaningless results.
If MSU crystals are confirmed, why not just score the remaining domains too?
▼
MSU crystal identification by polarizing light microscopy of synovial fluid, or from a tophus, is the gold standard for gout diagnosis. When confirmed, it is a sufficient criterion - no further scoring is needed and the patient classifies as gout immediately. The scored domains were designed for situations where crystal analysis is unavailable or has not been performed, which is common in primary care and early disease. The sufficient criterion recognizes that a positive crystal analysis is near-diagnostic by itself.
Why does a very low serum urate (<4 mg/dL) subtract 4 points?
▼
A serum urate below 4 mg/dL is considered evidence against gout - urate at this level is rarely sufficient to cause monosodium urate crystal formation and deposition. The subtraction reflects the low prior probability of gout in someone with persistently very low urate. However, an important caveat: serum urate can temporarily drop during an acute flare as urate redistributes into the inflamed joint. This is why the criteria specify scoring the highest value ever, ideally measured during the intercritical period (at least 4 weeks after a flare and not on urate-lowering therapy).
Why does MSU-negative synovial fluid subtract 2 points?
▼
A properly performed synovial fluid analysis by a trained examiner using polarizing microscopy that fails to identify MSU crystals is evidence against gout. Negative synovial fluid in a symptomatic joint is a meaningful finding that appropriately lowers the score. The key qualifiers are important: the analysis must be done by a trained examiner using polarizing microscopy from a symptomatic joint or bursa. If the analysis was not performed, no points are subtracted (score 0) - absence of a test is not the same as a negative result.
What exactly is the 'double contour sign' on ultrasound?
▼
The double-contour sign (DCS) is a hyperechoic (bright white) irregular enhancement over the surface of the hyaline cartilage that is independent of the insonation angle of the ultrasound beam. The second 'contour' represents urate crystal deposition on the cartilage surface. A critical technical note: a false-positive DCS artifact may appear at the cartilage surface that should disappear when the angle of the probe is changed. True DCS persists regardless of angle. It is most commonly seen at the first metatarsophalangeal joint and knee, and less frequently at more proximal joints and upper extremity joints.
What qualifies as a gout-related erosion on plain X-ray?
▼
For the radiographic criterion, erosion is specifically defined as a cortical break with a sclerotic margin and overhanging edge on conventional radiography (plain X-ray) of the hands or feet. Two anatomical exclusions apply: DIP (distal interphalangeal) joints are excluded, and the gull-wing appearance (which is characteristic of erosive osteoarthritis) does not qualify. The sclerotic margin and overhanging edge pattern - sometimes called a 'rat-bite' appearance - is characteristic of the periarticular tophaceous deposits that erode into bone in chronic gout.
Can I score both the ultrasound double-contour sign AND DECT?
▼
No - the imaging urate domain (domain G) is capped at 4 points regardless of how many imaging modalities are positive. The criterion awards 4 points for evidence of urate deposition by either ultrasound double-contour sign or DECT, not both. Similarly, domain H (radiographic erosion) is a separate 4-point domain that is scored independently. The maximum score from both imaging domains combined is 8 points (4 + 4).
What does 'time to maximal pain <24 hours' mean for the time-course criterion?
▼
This refers to the rapid escalation characteristic of acute gout - the pain goes from onset to peak severity in less than 24 hours. Combined with the other two time-course features (resolution in ≤14 days and complete resolution between episodes), this pattern reflects the stereotypical acute gout flare. A patient who develops gradual, slowly worsening joint pain over days to weeks would not meet this feature. Two of the three time-course features must be present to count as a 'typical episode.'
Does this calculator apply to someone currently on urate-lowering therapy (e.g., allopurinol)?
▼
Yes, the criteria apply to the patient's total disease experience - not just current status. However, serum urate should be scored at the highest value ever, ideally measured before urate-lowering therapy was started or during an intercritical period off treatment. A patient on allopurinol with a current urate of 4.5 mg/dL but a documented historical level of 9.2 mg/dL should be scored at 9.2 mg/dL (+3 points). The criteria note that if practicable, urate should be retested under intercritical conditions to obtain the most meaningful value.
What are the sensitivity and specificity of these criteria?
▼
In the SUGAR (Study for Updated Gout Classification Criteria) validation dataset of 330 patients, the full criteria demonstrated sensitivity of 92% and specificity of 89%. Using clinical parameters only (without synovial fluid microscopy or imaging, scored as 0), sensitivity was 85% and specificity was 78%. These performance characteristics are superior to all previously published gout classification criteria. The criteria perform well across a spectrum from early to established disease.
Is a tophus the same as confirmed MSU crystals for the sufficient criterion?
▼
A tophus can satisfy the sufficient criterion, but only if MSU crystals are confirmed from it - for example, by aspiration and polarizing microscopy, or by characteristic dual-energy CT appearance. A clinically suspected tophus (domain D, worth 4 points) is scored in the clinical domains when there is no crystal confirmation. For the sufficient criterion, the standard is confirmed MSU crystals in the tophus or synovial fluid, not just clinical appearance. A firm, chalky nodule in a typical location that has not been analyzed does not meet the sufficient criterion.
Are these criteria diagnostic or classification criteria?
▼
These are classification criteria, developed to standardize patient selection for clinical research - not for individual diagnosis. Classification criteria are designed to identify a relatively homogeneous group of well-characterized patients for studies, prioritizing specificity. A clinician may diagnose gout in a patient who does not formally meet these criteria (e.g., a patient with a single typical first MTP flare and urate of 7.5 who has not yet had imaging or synovial fluid analysis). Conversely, meeting the criteria does not bypass the need for clinical evaluation, exclusion of septic arthritis, and appropriate management decisions.